Loading…
Arlington Capital Partners announced the acquisition of Molecular Products Group, a manufacturer of advanced chemistry-based products for healthcare, defense and industrial markets. Molecular Products has facilities in Harlow, UK and Boulder, Colorado.
“We are excited to be partnering with CEO Troy Rhudy and his management team at Molecular Products to expand the Company’s unique position in the development of advanced chemistry-based applications.”arlingtoncap.com
Summarized from public sources; check the original articles before acting on it.